Benzinga | Jul 30, 2020 04:12PM EDT

Exact Sciences Q2 EPS $(0.58) Beats $(0.63) Estimate, Sales $268.90M Beat $228.42M Estimate

Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.63) by 7.94 percent. This is a 93.33 percent decrease over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $268.90 million which beat the analyst consensus estimate of $228.42 million by 17.72 percent. This is a 34.54 percent increase over sales of $199.87 million the same period last year.